| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01AA06 | B | Ifosfamide - 1g | 12354 | 22425/1 | HOLOXAN | 1g | 1 | Injectable powder for solution | Infusion | Abela Frères S.A.L. | Baxter Oncology GmbH | Germany | 3,586,716 L.L | 23.08 | B | Baxter Deutschland GmbH | Germany | 10/11/20 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01AA06 | B | Ifosfamide - 1g | 516 | 27263 | HOLOXAN | 1g | 1 | Injectable powder for solution | Infusion | Abela Frères S.A.L. | Baxter Oncology GmbH | Germany | 3,586,850 L.L | 23.08 | B | Baxter Oncology GmbH | Germany | 10/11/20 |

